Cravath’s London Office Moves to 100 Cheapside
Jesse M. Weiss has a broad litigation practice, with a particular focus on antitrust, including antitrust litigation, regulatory work and antitrust counseling.
Mr. Weiss’s representative matters include:
Antitrust Litigation
- Representing Live Nation in antitrust litigation filed by the U.S. Department of Justice (DOJ), 39 states and the District of Columbia seeking to break up Live Nation/Ticketmaster.
- Representing Elsevier in putative class action antitrust litigation filed in New York federal court alleging collusion among Elsevier and the world’s other largest for‑profit publishers of peer‑reviewed scholarly journals in violation of Section 1 of the Sherman Act.
- Represented Illumina in an administrative challenge brought by the Federal Trade Commission (FTC) concerning Illumina’s $8 billion acquisition of GRAIL, a healthcare company developing a cancer screening test for 50 cancer types. In September 2022, the FTC’s Chief Administrative Law Judge ruled in favor of Illumina and rejected the FTC’s challenge to the merger. Mr. Weiss represented Illumina on all antitrust issues in connection with the acquisition.
-
Represented Amgen in successfully defending against an FTC challenge to its $27.8 billion acquisition of Horizon Therapeutics, the largest in Amgen’s history. In September 2023, Amgen secured a consent order that ended all litigation and cleared the path for the deal to close. In connection with this victory, the Cravath team was recognized as The Am Law Litigation Daily’s “Litigators of the Week.”
- Representing Corteva in antitrust litigation brought by the FTC and 12 state attorneys general challenging certain of its rebate pricing programs as anticompetitive, as well as more than two dozen related putative class actions, centralized in North Carolina federal court, filed in the wake of the FTC’s complaint.
- Represented Tesla in consolidated putative class action antitrust litigation alleging it has monopolized access to parts and services needed to repair its vehicles, resulting in significant delays and supracompetitive pricing for Tesla vehicle maintenance.
- Represented American Express (“Amex”) in several antitrust litigations in New York federal court. Mr. Weiss previously represented Amex in a civil action brought by the DOJ and 17 state attorneys general. The case culminated in a nearly two‑month bench trial, which was followed by successful appeals in favor of Amex in both the Second Circuit and the Supreme Court.
Regulatory Clearance
- Represented PepsiCo on regulatory matters in connection with its $1.95 billion acquisition of poppi.
- Represented Star Bulk Carriers on antitrust issues in connection with its $2.1 billion combination with Eagle Bulk Shipping.
- Represented Cisco Systems on antitrust issues in connection with its $28 billion acquisition of Splunk.
- Represented CymaBay Therapeutics on antitrust issues in connection with its $4.3 billion acquisition by Gilead Sciences, Inc.
- Represented Altra Industrial Motion Corp. on antitrust issues in connection with its $5 billion acquisition by Regal Rexnord Corporation.
- Represented Atlas Air Worldwide Holdings on antitrust issues in connection with its $5.2 billion acquisition by an investor group led by funds managed by affiliates of Apollo Global Management.
- Represented Occidental Petroleum Corporation on antitrust issues in connection with its $57 billion acquisition of Anadarko Petroleum Corporation.
- Represented Barrick Gold Corporation in connection with the formation of a joint venture with Newmont Mining Corporation to combine their respective mining operations, assets, reserves and talent in Nevada.
- Represented Orbotech Ltd. in connection with its $3.4 billion acquisition by KLA-Tencor Corporation.
- Represented AveXis, Inc. in connection with its $8.7 billion acquisition by Novartis AG.
- Represented Alere Inc. in connection with its $8 billion sale to Abbott Laboratories.
- Represented Cameron International Corporation in connection with its $15 billion acquisition by Schlumberger Limited.
- Represented Delhaize Group in connection with its $29 billion merger with Royal Ahold N.V.
- Represented H.J. Heinz Company and 3G Capital in connection with Heinz’s $60 billion merger with Kraft Foods Group to form The Kraft Heinz Company.
- Represented RELX Group in connection with its acquisition of Aries Systems, its acquisition of Safe Banking Systems, its acquisition of ThreatMetrix, its acquisition of bepress and its acquisition of Appriss’s Crash and Project business group.
Mr. Weiss is from New Jersey. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. Mr. Weiss joined Cravath in 2008 and was elected a partner in 2023.
Mr. Weiss’s representative matters include:
Antitrust Litigation
- Representing Live Nation in antitrust litigation filed by the U.S. Department of Justice (DOJ), 39 states and the District of Columbia seeking to break up Live Nation/Ticketmaster.
- Representing Elsevier in putative class action antitrust litigation filed in New York federal court alleging collusion among Elsevier and the world’s other largest for‑profit publishers of peer‑reviewed scholarly journals in violation of Section 1 of the Sherman Act.
- Represented Illumina in an administrative challenge brought by the Federal Trade Commission (FTC) concerning Illumina’s $8 billion acquisition of GRAIL, a healthcare company developing a cancer screening test for 50 cancer types. In September 2022, the FTC’s Chief Administrative Law Judge ruled in favor of Illumina and rejected the FTC’s challenge to the merger. Mr. Weiss represented Illumina on all antitrust issues in connection with the acquisition.
-
Represented Amgen in successfully defending against an FTC challenge to its $27.8 billion acquisition of Horizon Therapeutics, the largest in Amgen’s history. In September 2023, Amgen secured a consent order that ended all litigation and cleared the path for the deal to close. In connection with this victory, the Cravath team was recognized as The Am Law Litigation Daily’s “Litigators of the Week.”
- Representing Corteva in antitrust litigation brought by the FTC and 12 state attorneys general challenging certain of its rebate pricing programs as anticompetitive, as well as more than two dozen related putative class actions, centralized in North Carolina federal court, filed in the wake of the FTC’s complaint.
- Represented Tesla in consolidated putative class action antitrust litigation alleging it has monopolized access to parts and services needed to repair its vehicles, resulting in significant delays and supracompetitive pricing for Tesla vehicle maintenance.
- Represented American Express (“Amex”) in several antitrust litigations in New York federal court. Mr. Weiss previously represented Amex in a civil action brought by the DOJ and 17 state attorneys general. The case culminated in a nearly two‑month bench trial, which was followed by successful appeals in favor of Amex in both the Second Circuit and the Supreme Court.
Regulatory Clearance
- Represented PepsiCo on regulatory matters in connection with its $1.95 billion acquisition of poppi.
- Represented Star Bulk Carriers on antitrust issues in connection with its $2.1 billion combination with Eagle Bulk Shipping.
- Represented Cisco Systems on antitrust issues in connection with its $28 billion acquisition of Splunk.
- Represented CymaBay Therapeutics on antitrust issues in connection with its $4.3 billion acquisition by Gilead Sciences, Inc.
- Represented Altra Industrial Motion Corp. on antitrust issues in connection with its $5 billion acquisition by Regal Rexnord Corporation.
- Represented Atlas Air Worldwide Holdings on antitrust issues in connection with its $5.2 billion acquisition by an investor group led by funds managed by affiliates of Apollo Global Management.
- Represented Occidental Petroleum Corporation on antitrust issues in connection with its $57 billion acquisition of Anadarko Petroleum Corporation.
- Represented Barrick Gold Corporation in connection with the formation of a joint venture with Newmont Mining Corporation to combine their respective mining operations, assets, reserves and talent in Nevada.
- Represented Orbotech Ltd. in connection with its $3.4 billion acquisition by KLA-Tencor Corporation.
- Represented AveXis, Inc. in connection with its $8.7 billion acquisition by Novartis AG.
- Represented Alere Inc. in connection with its $8 billion sale to Abbott Laboratories.
- Represented Cameron International Corporation in connection with its $15 billion acquisition by Schlumberger Limited.
- Represented Delhaize Group in connection with its $29 billion merger with Royal Ahold N.V.
- Represented H.J. Heinz Company and 3G Capital in connection with Heinz’s $60 billion merger with Kraft Foods Group to form The Kraft Heinz Company.
- Represented RELX Group in connection with its acquisition of Aries Systems, its acquisition of Safe Banking Systems, its acquisition of ThreatMetrix, its acquisition of bepress and its acquisition of Appriss’s Crash and Project business group.
Mr. Weiss is from New Jersey. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. Mr. Weiss joined Cravath in 2008 and was elected a partner in 2023.
Education
- J.D., 2008, Georgetown University Law Centermagna cum laude
- B.A., 2003, University of Maryland
Admitted In
- New York
Professional Affiliations
American Bar Association
New York City Bar Association
Rankings
Lawdragon
- 500 Leading Global Antitrust & Competition Lawyers (2025)
- 500 Leading Litigators in America (2025)
The Legal 500 US
- Antitrust (2025)
Deals & Cases
May 09, 2025
TaskUs’s Take‑Private Acquisition by its Co‑Founders and Blackstone
On May 9, 2025, TaskUs, Inc. (“TaskUs”), a leading provider of outsourced digital services and next‑generation customer experience to companies, announced it has entered into a definitive agreement to become a privately held company. Under the terms of the agreement, an affiliate of Blackstone, TaskUs Co‑Founder and Chief Executive Officer Bryce Maddock and TaskUs Co‑Founder and President Jaspar Weir (collectively the “Buyer Group”) will acquire 100% of the outstanding shares of Class A common stock they do not already own for $16.50 per share in an all-cash transaction. Upon completion of the transaction, the Company’s Class A common stock will no longer be listed on any public market. The TaskUs Board of Directors has approved the transaction upon the unanimous recommendation of a special committee of independent directors (the “Special Committee”), which was formed on March 20, 2025, in response to interest expressed by the Buyer Group in exploring a possible transaction. Cravath is representing the Special Committee in connection with the transaction.
Deals & Cases
April 07, 2025
IBM’s Acquisition of Hakkoda
On April 7, 2025, IBM announced it has acquired Hakkoda Inc., a leading global data and AI consultancy. Hakkoda will expand IBM Consulting’s data transformation services portfolio, adding specialized data platform expertise to help clients get their data ready to fuel AI‑powered business operations. Cravath is representing IBM in connection with the transaction.
Deals & Cases
March 17, 2025
PepsiCo’s $1.95 Billion Acquisition of poppi
On March 17, 2025, PepsiCo, Inc. (“PepsiCo”) announced that it has entered into a definitive agreement to acquire poppi, a prebiotic soda brand, for $1.95 billion, including $300 million of anticipated cash tax benefits for a net purchase price of $1.65 billion. The transaction also includes an additional potential earnout consideration subject to the achievement of certain performance milestones within a specified period after closing of the transaction. Cravath is representing PepsiCo in connection with the transaction.
Deals & Cases
February 18, 2025
Light & Wonder’s Acquisition of Grover Gaming’s Charitable Gaming Assets
On February 18, 2025, Light & Wonder, Inc. (“Light & Wonder”), the leading cross‑platform global games company, announced that it has entered into a definitive agreement to acquire the charitable gaming assets of Grover Gaming, Inc. and G2 Gaming, Inc. (together, “Grover Gaming”), a leading provider of electronic pull‑tabs for charitable gaming in the U.S., for total consideration of $850 million cash, subject to customary purchase price adjustments, and a four‑year revenue based earn‑out of up to $200 million cash. Cravath is representing Light & Wonder in connection with the transaction.
Deals & Cases
February 10, 2025
FactSet’s Acquisition of LiquidityBook
On February 10, 2025, FactSet, a global financial digital platform and enterprise solutions provider, announced the acquisition of LiquidityBook, a leading provider of cloud‑native buy- and sell‑side trading solutions, for a gross purchase price of $246.5 million in cash. Cravath is representing FactSet in connection with the transaction.
Activities
April 28, 2025
Jesse Weiss Speaks at Penn Carey Law Antitrust Association’s Annual Symposium
On April 18, 2025, Cravath partner Jesse M. Weiss participated in the Penn Carey Law Antitrust Association’s annual symposium, which was held at the University of Pennsylvania in Philadelphia. The symposium, entitled “Silicon Valley and the Sherman Act: Monopolization and Information Sharing in the Age of AI,” convened academics and antitrust practitioners to discuss topics related to monopolization and the implications of advancements in AI and technology for antitrust law. Jesse spoke on a panel about monopolization cases and issues in technology industries.
Publications
October 17, 2024
FTC Issues Final HSR Rules
On October 15, 2024, Cravath prepared a memo for its clients entitled “FTC Issues Final HSR Rules.” The memo examines the Federal Trade Commission and the Department of Justice Antitrust Division’s final version of the new Hart‑Scott‑Rodino (HSR) rules, which modify the initial proposed rules released in June 2023. The memo summarizes the HSR rules, which require parties to inform the agencies of proposed acquisitions through a filing process, including notable changes from the current and proposed rules and their implications for filing parties.
Publications
December 28, 2023
Merger Guidelines Issued by FTC and DOJ
On December 22, 2023, Cravath prepared a memo for its clients entitled “Merger Guidelines Issued by FTC and DOJ.” The memo examines the Federal Trade Commission and the Department of Justice Antitrust Division’s finalized Merger Guidelines, which modify the draft guidelines released in July and replace the 2010 Horizontal Merger Guidelines and the 2020 Vertical Merger Guidelines. The memo outlines the new guidelines and the additional changes made in finalizing them.
Activities
September 08, 2023
Cravath Team Named “Litigators of the Week” by The Am Law Litigation Daily for Successful Defense of Amgen Against FTC’s Challenge to Acquisition of Horizon Therapeutics
On September 8, 2023, The Am Law Litigation Daily featured a Cravath team, led by partners David R. Marriott and Timothy G. Cameron and of counsel Jesse M. Weiss, as “Litigators of the Week” for its successful defense of Amgen, one of the world’s largest biopharmaceutical companies, against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that ends all litigation and clears the path for the transaction to close.
Jesse M. Weiss has a broad litigation practice, with a particular focus on antitrust, including antitrust litigation, regulatory work and antitrust counseling.
Mr. Weiss’s representative matters include:
Antitrust Litigation
- Representing Live Nation in antitrust litigation filed by the U.S. Department of Justice (DOJ), 39 states and the District of Columbia seeking to break up Live Nation/Ticketmaster.
- Representing Elsevier in putative class action antitrust litigation filed in New York federal court alleging collusion among Elsevier and the world’s other largest for‑profit publishers of peer‑reviewed scholarly journals in violation of Section 1 of the Sherman Act.
- Represented Illumina in an administrative challenge brought by the Federal Trade Commission (FTC) concerning Illumina’s $8 billion acquisition of GRAIL, a healthcare company developing a cancer screening test for 50 cancer types. In September 2022, the FTC’s Chief Administrative Law Judge ruled in favor of Illumina and rejected the FTC’s challenge to the merger. Mr. Weiss represented Illumina on all antitrust issues in connection with the acquisition.
-
Represented Amgen in successfully defending against an FTC challenge to its $27.8 billion acquisition of Horizon Therapeutics, the largest in Amgen’s history. In September 2023, Amgen secured a consent order that ended all litigation and cleared the path for the deal to close. In connection with this victory, the Cravath team was recognized as The Am Law Litigation Daily’s “Litigators of the Week.”
- Representing Corteva in antitrust litigation brought by the FTC and 12 state attorneys general challenging certain of its rebate pricing programs as anticompetitive, as well as more than two dozen related putative class actions, centralized in North Carolina federal court, filed in the wake of the FTC’s complaint.
- Represented Tesla in consolidated putative class action antitrust litigation alleging it has monopolized access to parts and services needed to repair its vehicles, resulting in significant delays and supracompetitive pricing for Tesla vehicle maintenance.
- Represented American Express (“Amex”) in several antitrust litigations in New York federal court. Mr. Weiss previously represented Amex in a civil action brought by the DOJ and 17 state attorneys general. The case culminated in a nearly two‑month bench trial, which was followed by successful appeals in favor of Amex in both the Second Circuit and the Supreme Court.
Regulatory Clearance
- Represented PepsiCo on regulatory matters in connection with its $1.95 billion acquisition of poppi.
- Represented Star Bulk Carriers on antitrust issues in connection with its $2.1 billion combination with Eagle Bulk Shipping.
- Represented Cisco Systems on antitrust issues in connection with its $28 billion acquisition of Splunk.
- Represented CymaBay Therapeutics on antitrust issues in connection with its $4.3 billion acquisition by Gilead Sciences, Inc.
- Represented Altra Industrial Motion Corp. on antitrust issues in connection with its $5 billion acquisition by Regal Rexnord Corporation.
- Represented Atlas Air Worldwide Holdings on antitrust issues in connection with its $5.2 billion acquisition by an investor group led by funds managed by affiliates of Apollo Global Management.
- Represented Occidental Petroleum Corporation on antitrust issues in connection with its $57 billion acquisition of Anadarko Petroleum Corporation.
- Represented Barrick Gold Corporation in connection with the formation of a joint venture with Newmont Mining Corporation to combine their respective mining operations, assets, reserves and talent in Nevada.
- Represented Orbotech Ltd. in connection with its $3.4 billion acquisition by KLA-Tencor Corporation.
- Represented AveXis, Inc. in connection with its $8.7 billion acquisition by Novartis AG.
- Represented Alere Inc. in connection with its $8 billion sale to Abbott Laboratories.
- Represented Cameron International Corporation in connection with its $15 billion acquisition by Schlumberger Limited.
- Represented Delhaize Group in connection with its $29 billion merger with Royal Ahold N.V.
- Represented H.J. Heinz Company and 3G Capital in connection with Heinz’s $60 billion merger with Kraft Foods Group to form The Kraft Heinz Company.
- Represented RELX Group in connection with its acquisition of Aries Systems, its acquisition of Safe Banking Systems, its acquisition of ThreatMetrix, its acquisition of bepress and its acquisition of Appriss’s Crash and Project business group.
Mr. Weiss is from New Jersey. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. Mr. Weiss joined Cravath in 2008 and was elected a partner in 2023.
Mr. Weiss’s representative matters include:
Antitrust Litigation
- Representing Live Nation in antitrust litigation filed by the U.S. Department of Justice (DOJ), 39 states and the District of Columbia seeking to break up Live Nation/Ticketmaster.
- Representing Elsevier in putative class action antitrust litigation filed in New York federal court alleging collusion among Elsevier and the world’s other largest for‑profit publishers of peer‑reviewed scholarly journals in violation of Section 1 of the Sherman Act.
- Represented Illumina in an administrative challenge brought by the Federal Trade Commission (FTC) concerning Illumina’s $8 billion acquisition of GRAIL, a healthcare company developing a cancer screening test for 50 cancer types. In September 2022, the FTC’s Chief Administrative Law Judge ruled in favor of Illumina and rejected the FTC’s challenge to the merger. Mr. Weiss represented Illumina on all antitrust issues in connection with the acquisition.
-
Represented Amgen in successfully defending against an FTC challenge to its $27.8 billion acquisition of Horizon Therapeutics, the largest in Amgen’s history. In September 2023, Amgen secured a consent order that ended all litigation and cleared the path for the deal to close. In connection with this victory, the Cravath team was recognized as The Am Law Litigation Daily’s “Litigators of the Week.”
- Representing Corteva in antitrust litigation brought by the FTC and 12 state attorneys general challenging certain of its rebate pricing programs as anticompetitive, as well as more than two dozen related putative class actions, centralized in North Carolina federal court, filed in the wake of the FTC’s complaint.
- Represented Tesla in consolidated putative class action antitrust litigation alleging it has monopolized access to parts and services needed to repair its vehicles, resulting in significant delays and supracompetitive pricing for Tesla vehicle maintenance.
- Represented American Express (“Amex”) in several antitrust litigations in New York federal court. Mr. Weiss previously represented Amex in a civil action brought by the DOJ and 17 state attorneys general. The case culminated in a nearly two‑month bench trial, which was followed by successful appeals in favor of Amex in both the Second Circuit and the Supreme Court.
Regulatory Clearance
- Represented PepsiCo on regulatory matters in connection with its $1.95 billion acquisition of poppi.
- Represented Star Bulk Carriers on antitrust issues in connection with its $2.1 billion combination with Eagle Bulk Shipping.
- Represented Cisco Systems on antitrust issues in connection with its $28 billion acquisition of Splunk.
- Represented CymaBay Therapeutics on antitrust issues in connection with its $4.3 billion acquisition by Gilead Sciences, Inc.
- Represented Altra Industrial Motion Corp. on antitrust issues in connection with its $5 billion acquisition by Regal Rexnord Corporation.
- Represented Atlas Air Worldwide Holdings on antitrust issues in connection with its $5.2 billion acquisition by an investor group led by funds managed by affiliates of Apollo Global Management.
- Represented Occidental Petroleum Corporation on antitrust issues in connection with its $57 billion acquisition of Anadarko Petroleum Corporation.
- Represented Barrick Gold Corporation in connection with the formation of a joint venture with Newmont Mining Corporation to combine their respective mining operations, assets, reserves and talent in Nevada.
- Represented Orbotech Ltd. in connection with its $3.4 billion acquisition by KLA-Tencor Corporation.
- Represented AveXis, Inc. in connection with its $8.7 billion acquisition by Novartis AG.
- Represented Alere Inc. in connection with its $8 billion sale to Abbott Laboratories.
- Represented Cameron International Corporation in connection with its $15 billion acquisition by Schlumberger Limited.
- Represented Delhaize Group in connection with its $29 billion merger with Royal Ahold N.V.
- Represented H.J. Heinz Company and 3G Capital in connection with Heinz’s $60 billion merger with Kraft Foods Group to form The Kraft Heinz Company.
- Represented RELX Group in connection with its acquisition of Aries Systems, its acquisition of Safe Banking Systems, its acquisition of ThreatMetrix, its acquisition of bepress and its acquisition of Appriss’s Crash and Project business group.
Mr. Weiss is from New Jersey. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. Mr. Weiss joined Cravath in 2008 and was elected a partner in 2023.
Education
- J.D., 2008, Georgetown University Law Centermagna cum laude
- B.A., 2003, University of Maryland
Admitted In
- New York
Professional Affiliations
American Bar Association
New York City Bar Association
Rankings
Lawdragon
- 500 Leading Global Antitrust & Competition Lawyers (2025)
- 500 Leading Litigators in America (2025)
The Legal 500 US
- Antitrust (2025)
Deals & Cases
May 09, 2025
TaskUs’s Take‑Private Acquisition by its Co‑Founders and Blackstone
On May 9, 2025, TaskUs, Inc. (“TaskUs”), a leading provider of outsourced digital services and next‑generation customer experience to companies, announced it has entered into a definitive agreement to become a privately held company. Under the terms of the agreement, an affiliate of Blackstone, TaskUs Co‑Founder and Chief Executive Officer Bryce Maddock and TaskUs Co‑Founder and President Jaspar Weir (collectively the “Buyer Group”) will acquire 100% of the outstanding shares of Class A common stock they do not already own for $16.50 per share in an all-cash transaction. Upon completion of the transaction, the Company’s Class A common stock will no longer be listed on any public market. The TaskUs Board of Directors has approved the transaction upon the unanimous recommendation of a special committee of independent directors (the “Special Committee”), which was formed on March 20, 2025, in response to interest expressed by the Buyer Group in exploring a possible transaction. Cravath is representing the Special Committee in connection with the transaction.
Deals & Cases
April 07, 2025
IBM’s Acquisition of Hakkoda
On April 7, 2025, IBM announced it has acquired Hakkoda Inc., a leading global data and AI consultancy. Hakkoda will expand IBM Consulting’s data transformation services portfolio, adding specialized data platform expertise to help clients get their data ready to fuel AI‑powered business operations. Cravath is representing IBM in connection with the transaction.
Deals & Cases
March 17, 2025
PepsiCo’s $1.95 Billion Acquisition of poppi
On March 17, 2025, PepsiCo, Inc. (“PepsiCo”) announced that it has entered into a definitive agreement to acquire poppi, a prebiotic soda brand, for $1.95 billion, including $300 million of anticipated cash tax benefits for a net purchase price of $1.65 billion. The transaction also includes an additional potential earnout consideration subject to the achievement of certain performance milestones within a specified period after closing of the transaction. Cravath is representing PepsiCo in connection with the transaction.
Deals & Cases
February 18, 2025
Light & Wonder’s Acquisition of Grover Gaming’s Charitable Gaming Assets
On February 18, 2025, Light & Wonder, Inc. (“Light & Wonder”), the leading cross‑platform global games company, announced that it has entered into a definitive agreement to acquire the charitable gaming assets of Grover Gaming, Inc. and G2 Gaming, Inc. (together, “Grover Gaming”), a leading provider of electronic pull‑tabs for charitable gaming in the U.S., for total consideration of $850 million cash, subject to customary purchase price adjustments, and a four‑year revenue based earn‑out of up to $200 million cash. Cravath is representing Light & Wonder in connection with the transaction.
Deals & Cases
February 10, 2025
FactSet’s Acquisition of LiquidityBook
On February 10, 2025, FactSet, a global financial digital platform and enterprise solutions provider, announced the acquisition of LiquidityBook, a leading provider of cloud‑native buy- and sell‑side trading solutions, for a gross purchase price of $246.5 million in cash. Cravath is representing FactSet in connection with the transaction.
Activities
April 28, 2025
Jesse Weiss Speaks at Penn Carey Law Antitrust Association’s Annual Symposium
On April 18, 2025, Cravath partner Jesse M. Weiss participated in the Penn Carey Law Antitrust Association’s annual symposium, which was held at the University of Pennsylvania in Philadelphia. The symposium, entitled “Silicon Valley and the Sherman Act: Monopolization and Information Sharing in the Age of AI,” convened academics and antitrust practitioners to discuss topics related to monopolization and the implications of advancements in AI and technology for antitrust law. Jesse spoke on a panel about monopolization cases and issues in technology industries.
Publications
October 17, 2024
FTC Issues Final HSR Rules
On October 15, 2024, Cravath prepared a memo for its clients entitled “FTC Issues Final HSR Rules.” The memo examines the Federal Trade Commission and the Department of Justice Antitrust Division’s final version of the new Hart‑Scott‑Rodino (HSR) rules, which modify the initial proposed rules released in June 2023. The memo summarizes the HSR rules, which require parties to inform the agencies of proposed acquisitions through a filing process, including notable changes from the current and proposed rules and their implications for filing parties.
Publications
December 28, 2023
Merger Guidelines Issued by FTC and DOJ
On December 22, 2023, Cravath prepared a memo for its clients entitled “Merger Guidelines Issued by FTC and DOJ.” The memo examines the Federal Trade Commission and the Department of Justice Antitrust Division’s finalized Merger Guidelines, which modify the draft guidelines released in July and replace the 2010 Horizontal Merger Guidelines and the 2020 Vertical Merger Guidelines. The memo outlines the new guidelines and the additional changes made in finalizing them.
Activities
September 08, 2023
Cravath Team Named “Litigators of the Week” by The Am Law Litigation Daily for Successful Defense of Amgen Against FTC’s Challenge to Acquisition of Horizon Therapeutics
On September 8, 2023, The Am Law Litigation Daily featured a Cravath team, led by partners David R. Marriott and Timothy G. Cameron and of counsel Jesse M. Weiss, as “Litigators of the Week” for its successful defense of Amgen, one of the world’s largest biopharmaceutical companies, against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that ends all litigation and clears the path for the transaction to close.
Cravath Bicentennial
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.